Analysis by Product (Dialysis, Endoscopes & Endovision Systems, Lasers & Lithotripsy, Consumables & Accessories, Urodynamic Systems, Biopsy Devices, and others); by Disease (Kidney Disease, Urological Cancer & BPH, Pelvic Organ Prolapse, and Others); by Technology (Minimally Invasive, Robotic Surgery, and Others); and by End-User (Hospitals, Dialysis Centers, Ambulatory Surgical Centers, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Buy Now
The global urology devices market is estimated to garner a revenue of ~USD 63 Billion by the end of 2033 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 37 Billion in the year 2022. The growth of the market is primarily attributed to the rising prevalence of several kinds of urologic conditions across the globe, these diseases require quick medical attention owing to the discomfort and pain they cause. It is observed, more than 8 million people seek medical attention for urinary tract infections (UTIs) every year. In their lifetime, about 62% of women and 13% of men are estimated to experience at least one UTI in the United States.
Urology devices are medical devices that are used to diagnose various urologic disorders. They are technologically advanced to help treat several urologic conditions, including urinary tract infection (UTI), kidney disease, urethral cancer, urinary incontinence, urolithiasis, and others. Though the conditions such as UTIs and urinary incontinence seem not so hazardous disease, still these diseases have a huge influence on a large portion of the mass, especially elderly people, therefore, the rising prevalence of the geriatric population is fueling the growth of the market over the forecast period. According to the data released by the World Health Organization (WHO), the population of people aged between 60 and above is expected to increase to 1.4 billion by 2030 from 1 billion in 2020 globally. Further, the growing cases of diabetes and high blood pressure are also augmenting the demand for urology devices, as these diseases are the primary reasons for kidney failure. Also, with the rising preference for minimally invasive procedures, hospitals are opting for urological procedures such as endoscopy and laparoscopy which brings the need for urology devices in the medical settings.
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~7% |
|
Base Year Market Size (2022) |
~ USD 37 Billion |
|
Forecast Year Market Size (2033) |
~ USD 63 Billion |
|
Regional Scope |
|
Growth Drivers
Increasing Prevalence of Prostate Cancer - Prostate cancer is the second most common cancer in males. It was observed in a clinical report, in 2020, approximately 1,514,260 people were diagnosed with prostate cancer worldwide.
Upsurge in Bladder Cancer – According to the Centers for Disease Control and Prevention (CDC), around 57,000 men and 18,000 women are diagnosed with bladder cancer each year in the United States, and 12,000 men and 4,700 women die from the disorder.
Raise in Urinary Incontinence Cases – For instance, it is estimated that approximately 422 million people (20 and older age) worldwide suffer from urinary incontinence. Whereas, in the United States, urinary incontinence affects nearly 12 million people.
Escalating Healthcare Investment and Surge in Acquisitions – According to the World Economic Forum, the healthcare industry has witnessed a huge surge of investment, advancement, and new entrants from the diverse verticals of technology, telecommunications, and consumer sectors. Globally, USD 44 billion was raised in health innovation in 2021 on its own – twice as often as in 2020 – and the mergers and acquisitions of health and health tech companies increased by 50%.
Challenges
The global urology devices market is segmented and analyzed for demand and supply by disease into kidney disease, urological cancer & BPH, pelvic organ prolapse, and others, out of which, the kidney disease segment is estimated to significantly grow over the forecast period owing to the rising prevalence of end-stage kidney disease (ESKD), escalating demand for dialysis procedures, and surge in minimally invasive surgeries across the globe. For instance, end-stage renal disease, affected approximately 787,000 people in the United States as of 2020, with 70% of individuals undergoing dialysis. Further, the rising geriatric population that is more prone to kidney diseases, along with binge drinking issues, substance abuse, and adoption of an unhealthy lifestyle, are some other factors giving rise to kidney disorders and ultimately expanding the usage of urology devices in the next few years.
The global urology devices market is also segmented and analyzed for demand and supply by end-user into hospitals, dialysis centers, ambulatory surgical centers, and others. Out of all these, the hospital's segment is attributed to hold the largest share by the end of the forecast period owing to massive investments being made to develop hospital infrastructure, and the presence of a high number of hospitals around the word. Another major factor that positively contributes to the segment’s growth is the large patient pool visiting hospitals for treatment of urology-related disorders. Furthermore, hospital settings provide easy assistance for using urology endoscopes such as cystoscopies and ureteroscopy devices for the treatment and diagnosis of urolithiasis. The Organization for Economic Cooperation and Development (OECD) stated that the number of hospitals present in the United States grew from 5,564 in 2015 to 6,090 in 2019.
Our in-depth analysis of the global urology devices market includes the following segments:
|
By Product |
|
|
By Disease |
|
|
By Technology |
|
|
By End-User |
|
The North America urology devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033 backed by the increased number of patients diagnosed with kidney diseases, growing incidences of other urologic conditions, and favorable reimbursement policies in the region As per the Centers for Disease Control and Prevention (CDC), by 2023, approximately 37 million adults in the United States are expected to have chronic kidney disease, with the vast majority remaining undiagnosed. Also, the presence of a strong healthcare system and major key players in the region are considered to be other growth factors for the market. Moreover, the increased utilization rate of single-use cystoscopes for treatment purposes, along with the rise in the development of technologically advanced urology devices by market players, have been anticipated to fuel market growth in this region in the upcoming years. In addition, there has been increasing adoption of advanced level devices such as urology laser for the removing stone that are located in the urinary tract, that is expected to drive the market’s growth in the region.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: Rising prevalence of chronic kidney diseases (CKD), increasing prevalence of prostate cancer, upsurge in bladder cancer, and raise in urinary incontinence cases are some major factors driving the growth of the market.
Ans: The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 – 2033.
Ans: High costs of urology devices, rising concerns about the risks associated with urologic surgeries, and stringent government rules for approval of novel treatment methods are estimated to hamper the market growth.
Ans: The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
Ans: The major players in the market are Boston Scientific Corporation, KARL STORZ SE & Co. KG, Becton, Dickinson and Company (BD), Richard Wolf GmbH, Intuitive Surgical, Inc., Fresenius Medical Care AG & Co. KGaA, Olympus Corporation, Coloplast, Medtronic, Stryker Corporation, and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product, disease, technology, end-user, and by region.
Ans: The kidney disease segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
